CAHP Statement: California Senate Votes on Widely-Supported Drug Price Transparency Bill
The California State Senate Committee on Health is set to vote today on SB 17, which responds to growing concerns over the impacts of drug companies’ efforts to push the limits on prescription drug prices that have left California families and state programs grappling with the realities of six-figure price tags for common medications.
Runaway Rx: Infographic – SB 17: Transparency in Drug Pricing
Runaway Rx: Infographic - SB 17: Transparency in Drug Prici…
Runaway Rx: Bipartisan Support for Drug Price Transparency
Runaway Rx: Bipartisan Support for Drug Price Transparency
CAHP Statement: Health Plans Statement on SB 17 (Hernandez)
State Senator Ed Hernandez (D-West Covina) was joined by consumer advocates, labor representatives and other California leaders today as he introduced SB 17, which will bring much-needed transparency to prescription drug pricing. The introduction of SB 17 marks the third time in three years that California legislators have pushed to shine a light on how the pharmaceutical industry prices its products.
Runaway Rx: Shedding Light on Prescription Drug Pricing
Runaway Rx: Shedding Light on Prescription Drug Pricing
Runaway Rx: February 2017 News Roundup
Runaway Rx: February 2017 News Roundup
Runaway Rx: California Assembly Health Informational Hearing – Rising Cost of Prescription Drugs
Runaway Rx: California Assembly Health Informational Hearing…
Runaway Rx: WSJ: Marathon Pharmaceuticals to Charge $89,000 for Muscular Dystrophy Drug After 70-Fold Increase
Runaway Rx: WSJ: Marathon Pharmaceuticals to Charge $89,000…
Runaway Rx: 9 of 10 Top Drugmakers Spend More on Marketing than Research
Runaway Rx: 9 of 10 Top Drugmakers Spend More on Marketing than…
Runaway Rx: 2017 News Roundup
Runaway Rx: 2017 News Roundup